Description
ARA-290, also known as Cibinetide, is a synthetic 11-residue peptide derived from a surface region of erythropoietin and supplied for controlled laboratory, analytical, and scientific research. Its N-terminal residue is pyroglutamate (pGlu), which is an important part of its molecular identity.
The commonly referenced parent peptide has the molecular formula C₅₁H₈₄N₁₆O₂₁ and an average molecular weight of approximately 1257.3 g/mol.
For accurate technical documentation, the exact terminal state, salt or counter-ion form, purity specification, and lot-specific analytical profile should be confirmed using the applicable Certificate of Analysis.
Research Applications
ARA-290 may be examined in controlled non-clinical research involving:
Peptide identity and characterization
Ligand-receptor interaction studies
Structure-function analysis
Molecular signaling research
Modified-residue characterization
Comparative peptide analysis
Stability assessment
Non-clinical biochemical and cellular models
Experimental observations should remain specific to the applicable research system and should not be interpreted as evidence of neurological, tissue-protective, anti-inflammatory, therapeutic, or clinical effectiveness.
Structural Information
ARA-290 is commonly represented as:
pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
The peptide contains 11 residues, with an N-terminal pyroglutamate modification and a free C-terminal carboxyl group.
Key structural characteristics include:
11-residue peptide chain
N-terminal pyroglutamate
Defined linear peptide sequence
Free C-terminal carboxyl group
Erythropoietin-derived helix-surface sequence
Because pyroglutamate is a non-standard residue, a conventional one-letter amino-acid sequence does not fully represent the molecular structure.
Analytical Identification
Relevant analytical characterization may include:
Amino-acid sequence confirmation
Pyroglutamate verification
Molecular mass assessment
Chromatographic purity testing
Peptide identity verification
Terminal-state confirmation
Structural characterization
Lot-specific quality analysis
Specifications & Documentation
Lot-specific documentation should be reviewed for:
ARA-290 / Cibinetide identity
CAS number
Amino-acid sequence
Molecular formula
Molecular weight
N-terminal pyroglutamate
Terminal form
Salt or counter-ion form
Purity specification
Analytical testing
Lot or batch information
Certificate of Analysis
Storage requirements
Authenticated product-specific documentation should take precedence over generalized catalog references.
Storage & Handling
Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.
Handling should follow established laboratory procedures appropriate for modified research peptide materials.
Research Use Only
ARA-290 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.
Disclaimer
For research use only. Not for human or veterinary use. Not intended for consumption, administration, neurological use, tissue-protective use, anti-inflammatory use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, neurological, tissue-protective, anti-inflammatory, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.
